Therapeutic Use of Cannabis and Cannabinoids
Evidence is insufficient for the use of cannabis or cannabinoids for most medical indications. Clear guidance from clinicians is essential to support safe, evidence-based decision-making. Clinicians should weigh benefits against risks when engaging patients in informed discussions about cannabis or cannabinoid use.
Authors
- Ayana Jordan (ORCID: https://orcid.org/0000-0002-7850-8096)
- Arya Shah (ORCID: https://orcid.org/0000-0002-2649-1835)
- Michael Hsu (ORCID: https://orcid.org/0000-0001-8868-8273)
- Kevin P. Hill (ORCID: https://orcid.org/0000-0001-5577-9128)
- Mark S. Gold
Institutions
- Beth Israel Deaconess Medical Center (US)
- Harvard University (US)
- University of California, San Francisco (US)
- Washington University in St. Louis (US)
- Neurobehavioral Systems (US)
- VA Greater Los Angeles Healthcare System (US)
- New York University (US)
Publication Details
- Journal
- JAMA
- Published
- 2025-11-26
- DOI
- https://doi.org/10.1001/jama.2025.19433
- Citations
- 4
- Primary Topic
- Cannabis and Cannabinoid Research
- Type
- article
- Field-Weighted Citation Impact
- 5.58